SCHEMBL25664231

SCHEMBL25664231

CC(=O)N[C@H](C#N)C[C@@H]1CCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24113346 0.92 CTSL (0.47) —
SCHEMBL24740251 0.87 — —
SCHEMBL24113375 0.84 CTSS (0.46) —
SCHEMBL24020754 0.82 — —
SCHEMBL24112532 0.82 CTSS (0.51) —
SCHEMBL28839694 0.82 CTSS (0.51) —
SCHEMBL25761959 0.82 CTSL (0.55) —
SCHEMBL24020458 0.82 CTSS (0.51) —
SCHEMBL24021038 0.82 CTSL (0.49) —
SCHEMBL24019848 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760722-B2 Inhibitors of cysteine proteases and methods of use thereof ASCLETIS BIOSCIENCE CO., LTD. (CN) 2023-09-19 — — US disclosed
US-20230234921-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF ASCLETIS BIOSCIENCE CO., LTD. (CN) 2023-07-27 — — US disclosed
US-20230159451-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF ASCLETIS BIOSCIENCE CO., LTD. (CN) 2023-05-25 — — US disclosed
Send feedback